ACE and diabetes mellitus: This decrease needs to be discussed with respect to the warning published by the European Medicines Agency in 2012 that the combination of aliskiren with ACE inhibitors and ARBs is no longer recommended for patients and is contraindicated in patients with diabetes or kidney problems [13].